Yuhan Corporation's Glycemic Lactobacillus Saccharolac Strain Wins Jang Young-sil Award
Oct 20, 2025
The strain of 'L.plantarum HAC01' of Yuhan's glycemic lactic acid bacteria 'L.plantarum HAC01' won the IR52 Jang Young-sil Award in recognition of its excellence. The IR52 Jang Young-sil Award is a system that selects and awards new technology products and products with excellent technological innovation performance.
'L.plantarum HAC01' is a blood sugar functional individually recognized probiotic developed by its subsidiary, microbiome company AtoGen, after a research period of about 10 years. Through human application tests, L.plantarum HAC01 has been confirmed to help suppress blood sugar rise after two hours of meals and reduce glycated hemoglobin (HbA1c), and is a raw material for blood sugar functional lactic acid bacteria that has been recognized for its functionality and safety by the Ministry of Food and Drug Safety in 2022.
In recognition of its excellent functionality, it won the Patent and Trademark Office's Patent Technology Award in 23, and ranked first in the intestinal microorganism control raw material category at the 'Neutraint-Asia Awards 2024' held in Thailand in 24. The Jang Young-sil Award was highly regarded for its technological prowess in the field of probiotics and the development of scientific evidence-based raw materials, and it was evaluated that it presented the possibility of a 'probiotic-based metabolic health solution' as a new solution to blood sugar management.
Products with L.plantarum HAC01 as the main ingredients include Yuhan's 'Dang Qurak' and E2Gen's 'Dr. Myol's blood sugar Lactobacillus HAC01'. Both products are complex functional probiotics that suppress postprandial blood sugar rise and help grow intestinal beneficial bacteria, pioneering a new health functional food category that simultaneously cares for blood sugar management and intestinal health.
Since its launch, Yuhan Corporation's Dang Qurak has surpassed 50 billion won in cumulative sales, and is steadily growing, focusing on home shopping and online channels. Based on HAC01's technology, Yuhan plans to continue expanding its line-up dedicated to blood sugar management and strengthening its microbiome-based metabolic health product line.
'L.plantarum HAC01' is a blood sugar functional individually recognized probiotic developed by its subsidiary, microbiome company AtoGen, after a research period of about 10 years. Through human application tests, L.plantarum HAC01 has been confirmed to help suppress blood sugar rise after two hours of meals and reduce glycated hemoglobin (HbA1c), and is a raw material for blood sugar functional lactic acid bacteria that has been recognized for its functionality and safety by the Ministry of Food and Drug Safety in 2022.
In recognition of its excellent functionality, it won the Patent and Trademark Office's Patent Technology Award in 23, and ranked first in the intestinal microorganism control raw material category at the 'Neutraint-Asia Awards 2024' held in Thailand in 24. The Jang Young-sil Award was highly regarded for its technological prowess in the field of probiotics and the development of scientific evidence-based raw materials, and it was evaluated that it presented the possibility of a 'probiotic-based metabolic health solution' as a new solution to blood sugar management.
Products with L.plantarum HAC01 as the main ingredients include Yuhan's 'Dang Qurak' and E2Gen's 'Dr. Myol's blood sugar Lactobacillus HAC01'. Both products are complex functional probiotics that suppress postprandial blood sugar rise and help grow intestinal beneficial bacteria, pioneering a new health functional food category that simultaneously cares for blood sugar management and intestinal health.
Since its launch, Yuhan Corporation's Dang Qurak has surpassed 50 billion won in cumulative sales, and is steadily growing, focusing on home shopping and online channels. Based on HAC01's technology, Yuhan plans to continue expanding its line-up dedicated to blood sugar management and strengthening its microbiome-based metabolic health product line.
|
This article was translated by Naver AI translator.
